Although CpG ODN was also found to modulate the functions of TLR9-expressing MDSCs23, 47, it could not directly activate MDSCs to stimulate anti-tumour cytokines23 and failed to prove efficacious in human clinical trials48, 49. This evidence concerns the gene TLR9 and neoplasm.